Skip to main content
. 2019 Jan 23;14(1):e0210909. doi: 10.1371/journal.pone.0210909

Fig 3.

Fig 3

(A-C) LDLR, SREBF2 and ABCA1 mRNA relative expression in CHD patients (n = 65) and HS (n = 30); (D-F) LDLR, SREBF2 and ABCA1 mRNA relative expression in obstructive (n = 69) and non-obstructive CHD patients (n = 26); (G-I) LDLR, SREBF2 and ABCA1 mRNA relative expression in CHD patients with coronary stenosis <50% (n = 39) and coronary stenosis ≥50% (n = 26) compared to HS (n = 30) (*p value<0.05 vs HS; **p value<0.01 vs HS; §p value <0.05 coronary stenosis ≥50% vs coronary stenosis <50%).